LFKRI Seminar Series

2020 Seminars

All seminars will be held at New York Blood Center - 310 East 67th Street, NYC.

Thursday, April 23, 2020 – 12PM
“Audaces fortuna adjuvant – Designing and using next generation adjuvants for vaccines and immunotherapies”
Darrick Carter Ph.D.
CEO, PAI Life Sciences Inc., Affiliate Professor, School of Medicine, Medical Genetics, University of Washington

POSTPONED TO LATER DATE
“Resolution of inflammation depends on Nuclear Receptor Nur77”
Carlie JM de Vries, PhD
Professor and Chair Department of Medical Biochemistry, Amsterdam University Medical Center, The Netherlands

POSTPONED TO LATER DATE
“The role of mDia2 in terminal maturation of red blood cells”
Peng Ji, MD, PhD
Associate Professor, Department of Pathology, Director, Pathology Physician-Scientist Training Program, Northwestern University.

Thursday, February 27, 2020 - 11AM
“When Epigenetics Meet Metabolism in Hematopoiesis”
Jian Xu, PhD
Associate Professor, Children’s Research Institute, UT Southwestern Medical Center

Thursday, February 13, 2020 - 11AM
“Beating swords into plowshares: the use of Fc receptor modification to develop a neutrophil extracellular trap targeted therapy for the treatment of sepsis”
Kandace Gollomp, MD
Instructor, Department of Pediatrics, Attending Physician, Division of Hematology, Children's Hospital of Philadelphia

Thursday, December 19, 2019 - 11AM
“Global Aspects in Cellular Therapy: Standards, Science & Unproven Therapies”
Joseph Schwartz, MD, MPH
Director, Transfusion Medicine Services, Professor of Pathology & Cell Biology, Columbia University Medical Center

+ 2019 Seminars
Thursday, October 24, 2019 -- 11AM
“Pathophysiological consequences of iron overload: lesson from a mouse model of type IV hereditary hemochromatosis
Sandro Altamura, PhD
Post-doctoral Fellow, University of Heidelberg and European Molecular Biology Laboratory (EMBL), Germany
Wednesday, October 2, 2019 – 10AM
“ From epidemiology to single-cell analysis: recent insights into malaria and sickle cell disease”
Bronner Goncalves, MD, MPH, PhD
Bioinformatics Scientist, National Institutes of Health and Medical Science & Computing, LLC
Tuesday, September 24, 2019 – 11AM
“The 100,000 Genomes Project: New Genes for Rare Blood Diseases”
Willem H. Ouwehand, MD, PhD
Professor of Experimental Hematology, University of Cambridge
Tuesday, August 20, 2019 – 11AM
“Banking With Precision: Predicting Red Blood Cell Phenotypes from Next Generation Sequencing Data”
Celina Montemayor, MD, PhD
Staff Clinician, Assistant Clinical Investigator, Department of Transfusion Medicine, National Institutes of Health Clinical Center
Tuesday, June 18, 2019 – 1PM
“Characterizing Social Support Within the Sexual Networks of Gay Men: Implications for HIV Prevention Strategies”
Jorge H. Soler, PhD, MPH
Postdoctoral Fellow, HIV Center for Clinical and Behavioral Studies, Columbia University & New York State Psychiatric Institute
Wednesday, May 8, 2019 – 1PM
“Old Pathways and New Players in Anemia of Chronic Disease and Diamond Blackfan Anemia”
Lionel Blanc, PhD
Associate Professor of Molecular Medicine and Pediatrics, The Feinstein Institute for Medical Research, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Friday, March 22, 2019 - 11AM
"SARS and MERS coronaviruses: cross-species transmission and vaccine design"
Fang Li, PhD
Associate Professor, Dept Veterinary andBiomedical Sciences, University of Minnesota Twin Cities
Wednesday, January 30, 2019 - 10AM
“Molecular Drivers of Platelet Production”
Joseph Italiano, PhD
Associate Professor of Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston Children’s Hospital
+ 2018 Seminars
Wednesday, December 12, 2018 - 10AM
“Mitochondrial Dynamics and Intracellular Calcium Signaling Regulate Hematopoietic Stem Cell Function”
Larry Luchsinger, PhD
Associate Research Scientist, Department of Medicine, Columbia University Medical Center
Thursday, November 1, 2018 - 10AM
“3D Bone Marrow modelling to document megakaryocyte functional regulation and diseases ”
Alessandra Balduini, MD
Associate Professor, University of Pavia, Italy; Research Associate Professor, Tufts University, Boston, MA
Thursday, October 18, 2018 - 11AM
“In vitro studies of erythropoiesis”
Ashley Toye, PhD
Principal Investigator, UK NHS-Blood & Transplant, and Senior Lecturer in Erythrocyte Biology, Department of Biochemistry, University of Bristol, UK
Thursday, October 11, 2018 - 11AM
“Thrombopoietic Agents in 2018: Ten Years Later”
James Bussel, MD
Professor Emeritus of Pediatrics, Weill Cornell Medical School, New York
Thursday, October 4, 2018 - 11AM
“Exploring the role of TAM (Tyro3_Axl_Mertk) receptors as a novel innate immune checkpoint in cancer immunotherapy"
Hind Medyouf, PhD
Group Leader, Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany
Thursday, September 13, 2018 - 11:30AM
"Blood Center Considerations for Cellular Product Collections and Distribution"
Robert J. Tressler PhD
Vice President of Laboratories at San Diego Blood Bank
Thursday, September 6, 2018 - 11AM
“Modeling HIV pathogenesis, prevention and novel therapies in humanized mice”
Ramesh Akkina, DVM, PhD
Professor, Department of Microbiology, Immunology and Pathology, Colorado State University
Wednesday, August 29, 2018 - 1PM
"Setting up biobanks and translation research services in academia; experiences and challenges"
Hassana Fathallah, PhD
Director, Clinical Trials Scientific Affairs, ACM Global Laboratories, Rochester, New York
WEDNESDAY, AUGUST 22, 2018 - 1PM
“The role of CDMO's in the commercialization of cell therapy"
Ruud Hulspas, PhD
Founder, Cellular Technologies Bio-consulting, LLC, Rockville, MD
MONDAY, JULY 9, 2018 - 11AM
"Pulmonary Inflammation in Sickle Cell Disease"
Jeffrey A. Glassberg, M.D.
Associate Professor of Hematology and Medical Oncology, and Emergency Medicine, Mount Sinai School of Medicine, New York
THURSDAY, JUNE 14, 2018 - 11AM
“Apheresis Collection for T cell Manufacturing: What’s in the bag and why do we care?”
Andrew D. Fesnak, MD
Assistant Professor, Director, Manufacturing, Clinical Cell and Vaccine Production Facility, University of Pennsylvania
FRIDAY, APRIL 20, 2018 - 12PM
"Patient Blood Management in Sickle Cell Disease"
France Pirenne, MD, PhD
Medical and Scientific Director, Etablissement Français du Sang, Créteil, Professor of Hematology, Institut Mondor de Recherche Biomédicale, lNSERM
FRIDAY, MARCH 30, 2018 - 11AM
"Barriers and Facilitators to Potential Future Biomedical HIV Prevention Products in Transgender and Cisgender Women"
Christine Rael, PhD
Postdoctoral Research Fellow, HIV Center for Clinical and Behavioral Studies, Columbia University
THURSDAY, FEBRUARY 22, 2018 - 11AM
"Role of Tissue Factor in Hemostasis, Thrombosis and Viral Infections"
Nigel Mackman, PhD, FAHA
John C. Parker
Distinguished Professor of Medicine, Co-Director of the Thrombosis and Hemostasis Program, University of North Carolina at Chapel Hill
+ 2017 Seminars
MONDAY, DECEMBER 4, 2017 - 11AM
"Armored Chimeric Antigen Receptor (CAR) T Cells for Solid Tumor Malignancies"
Oladapo Yeku, MD, PhD
Medical Oncology Fellow, Memorial Sloan Kettering Cancer Center
THURSDAY, NOVEMBER 30, 2017 - 11AM
"Type 1 Interferons Promote Alloimmune Responses to Transfused RBC Antigens"
David Gibbs, MD, PhD
Transfusion Medicine/Blood Bank Fellow, Department of Laboratory Medicine, Yale University
TUESDAY, NOVEMBER 28, 2017 - 11AM
"Stem Cell-Derived Megakaryocytes Tool for Translational Research and Source of Cellular Therapies"
Camelia Iancu-Rubin, PhD
Associate Professor, Scientific Director, Hematological Malignancies Tissue Bank, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
MONDAY, NOVEMER 20, 2017 - 11AM
"Investigations into the AML Cell Surfaceome"
Fabiana Perna, MD, PhD
Senior Research Scientist, Memorial Sloan Kettering Cancer Center, New York
THURSDAY, November 16, 2017 - 11AM
"Insights into Immune Defects in Rag-deficiency and Stem Cell Collections for Gene Therapy in Sickle Cell Anemia"
John Manis, MD
Associate Director of Transfusion Medicine, Boston Children's Hospital, Harvard Medical School
THURSDAY, OCTOBER 12, 2017 - 11AM
"Heterogeneity Assays and Platelet Lysate: Challenges and Chances for Stem Cell Therapies Development"
Richard Schaefer, MD
Head of Department Cell Therapeutics & Cell Processing, German Red Cross, Goethe-University Hospital, Frankfurt, Germany
THURSDAY, SEPTEMBER 7, 2017 - 11AM
"Exploring the Human Microbiome"
Tao Ding, PhD
Postdoctoral Researcher, Department of Biology, Center for Genomics and Systems Biology, New York University
MONDAY, AUGUST 21, 2017 - 11AM
"Inflammasomes and Danger Signals during Infection by Intracellular Pathogens"
David M. Ojcius, PhD
Professor and Chair, Department of Biomedical Sciences, University of the Pacific,Arthur A. Dugoni School of Dentistry
MONDAY, JULY 24, 2017 - 2PM
"Inflammatory Modulation of the Bone Marrow Hematopoietic Niche"
Leslie E. Silberstein, MD
Director, Joint Program in Transfusion Medicine, Professor, Harvard Medical School
THURSDAY, JULY 20, 2017 - 11AM
"Dickkopf-1: The Wnt Antagonist Becomes a Novel Immunomodulator"
Wook-Jin Chae, PhD
Associate Research Scientist, Department of Immunobiology, Yale University School of Medicine
MONDAY, JULY 17, 2017 - 1PM
“Making Platelets In Vitro from Pluripotent Stem Cells: Going Beyond Transfusion and Blood Clotting”
Cedric Ghevaert, MD, PhD
Consultant Hematologist, Senior Lecturer in Transfusion Medicine, Department of Hematology, University of Cambridge, UK
THURSDAY, MAY 18, 2017 - 11AM
“The Mechanism of Action of Anti-D in Preventing Hemolytic Disease of the Fetus and Newborn: What Do We Really Know?”
Alan H. Lazarus, PhD
Scientist, St. Michael's Hospital and Canadian Blood Services, Professor of Medicine, University of Toronto
WEDNESDAY, APRIL 5, 2017 - 1PM
“Genetics and Metabolomics of Blood Storage”
James C. Zimring, MD, PhD
Director and Chief Scientific Officer, BloodworksNW Research Institute, Professor, Department of Lab Medicine and Department of Medicine, University of Washington School of Medicine
THURSDAY, MARCH 2, 2017 - 11AM
“Insights into ZIKV Epidemiology, Diagnostics and Pathogenesis from Studies of Blood Donors and Recipients”
Michael Busch, MD, PhD
Director and VP, Research and Scientific Affairs, Blood Systems Research Institute
THURSDAY, FEBRUARY 16, 2017 - 11AM
“Engineering of Complex Tissues - New Possibilities for Drug Development and Regenerative Medicine”
Jan Hansmann, PhD
Group Leader, University Hospital of Würzburg, Fraunhofer Institute of Interfacial Engineering and Biotechnology

Want more information?

Email: TDeVard@nybloodcenter.org
Office: (212) 570-3136

About LFKRI